CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
Jong Pil Im
Intest Res. 2017;15(2):147-148.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.147

Excel Download

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
Intestinal Research. 2017;15(2):147   Crossref logo
Link1 Link2 Link3

Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
Annals of Coloproctology. 2019;35(5):225-226   Crossref logo
Link1 Link2 Link3

A retrospective comparison of infliximab versus adalimumab as induction and maintenance therapy for Crohn disease
Internal Medicine Journal. 2016;46(7):798-804   Crossref logo
Link1

A unique 3D endoanal ultrasound feature of perianal Crohn’s fistula: the ‘Crohn ultrasound fistula sign’
Colorectal Disease. 2012;14(9):e608-e611   Crossref logo
Link1

Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
Journal of Coloproctology. 2014;34(3):154-158   Crossref logo
Link1 Link2

Letter: infliximab vs. adalimumab in treating ambulatory perianal fistulising Crohn's disease
Alimentary Pharmacology & Therapeutics. 2014;40(2):218-220   Crossref logo
Link1

Evaluation of a Seton Procedure Combined With Infliximab Therapy (Early vs. Late) in Perianal Fistula With Crohn Disease
Annals of Coloproctology. 2019;35(5):249-253   Crossref logo
Link1 Link2 Link3

Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab: A Randomized Trial
Yearbook of Gastroenterology. 2008;2008:133-135   Crossref logo
Link1 Link2

568 – Higher Infliximab and Adalimumab Trough Levels are Not Associated with Fistula Healing in Patients with Fistulising Perianal Crohn's Disease
Gastroenterology. 2019;156(6):S-112   Crossref logo
Link1 Link2

P586 Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease
Journal of Crohn's and Colitis. 2020;14(Supplement_1):S490-S491   Crossref logo
Link1 Link2